A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature

被引:119
|
作者
Zohar, Joseph [1 ,2 ]
Stahl, Stephen [3 ]
Moller, Hans-Jurgen [4 ]
Blier, Pierre [5 ]
Kupfer, David [6 ]
Yamawaki, Shigeto [7 ]
Uchida, Hiroyuki [8 ]
Spedding, Michael [9 ]
Goodwin, Guy M. [10 ]
Nutt, David [11 ]
机构
[1] Tel Aviv Univ, Sheba Med Ctr, Dept Psychiat, Tel Hashomer, Israel
[2] Tel Aviv Univ, Sackler Sch Med, Tel Hashomer, Israel
[3] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA
[4] Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany
[5] Univ Ottawa, Dept Psychiat & Cellular & Mol Med, Ottawa, ON K1Z 7K4, Canada
[6] Univ Pittsburgh, Dept Psychiat, Med Ctr, Pittsburgh, PA USA
[7] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Psychiat & Neurosci, Hiroshima, Japan
[8] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan
[9] Spedding Res Solut SARL, F-78110 Le Vesinet, France
[10] Warneford Hosp, Univ Dept, Oxford OX3 7JX, England
[11] Univ London Imperial Coll Sci Technol & Med, Div Brain Sci, Ctr Neuropsychopharmacol, London, England
关键词
Psychotropic drugs; Nomenclature; Pharmacological domain; Mode of action; Neuroscience; Adherence; ANXIETY DISORDERS; METAANALYSIS; ANTIDEPRESSANTS; EFFICACY; DRUGS;
D O I
10.1016/j.euroneuro.2015.08.019
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neuroscience based Nomenclature (NbN) is a new system of classifying psychotropic drugs by their pharmacological profile. The NbN was developed to replace the current indication-based nomenclature and to provide an up-to-date and more useful framework to better inform pharmacological decisions. NbN provides updated relevant and specific scientific, regulatory and clinical information, aiming to support rational and lucid prescribing. This pharmacologically driven nomenclature, which highlights pharmacological domains and modes of action, may also increase drug adherence as it clarifies the rationale for selecting a specific psychotropic agent. (C) 2015 Published by Elsevier B.V.
引用
收藏
页码:2318 / 2325
页数:8
相关论文
共 50 条
  • [1] A Neuroscience-Based Nomenclature (NbN) for Psychotropic Agents
    Frazer, Alan
    Blier, Pierre
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 (08):
  • [2] Neuroscience-Based Nomenclature for Psychotropic Medication
    Hutson, Elizabeth
    Ellington, Erin
    Hardy, Lyons
    [J]. JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2023, 61 (07) : 9 - 13
  • [3] Progress on the Neuroscience-Based Nomenclature (NbN) for Psychotropic Medications
    Blier, Pierre
    Oquendo, Maria A.
    Kupfer, David J.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2017, 42 (10) : 1927 - 1928
  • [4] Progress on the Neuroscience-Based Nomenclature (NbN) for Psychotropic Medications
    Pierre Blier
    Maria A Oquendo
    David J Kupfer
    [J]. Neuropsychopharmacology, 2017, 42 : 1927 - 1928
  • [5] Neuroscience-based nomenclature (NbN)
    Worley, Luke
    [J]. LANCET PSYCHIATRY, 2017, 4 (04): : 272 - 273
  • [6] The importance of the neuroscience-based nomenclature
    Zohar, Joseph
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 7 - 7
  • [7] Neuroscience-based nomenclature in Ukraine
    Zubatiuk, O.
    Nosova, E.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S663 - S663
  • [8] Neuroscience-based nomenclature (jNbN) to replace traditional terminology of psychotropic medications
    Moeller, Hans-Juergen
    Schmitt, Andrea
    Falkai, Peter
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2016, 266 (05) : 385 - 386
  • [9] Neuroscience-based nomenclature (jNbN) to replace traditional terminology of psychotropic medications
    Hans-Jürgen Möller
    Andrea Schmitt
    Peter Falkai
    [J]. European Archives of Psychiatry and Clinical Neuroscience, 2016, 266 : 385 - 386
  • [10] Editorial: Neuroscience-based Nomenclature (NbN) replaces the current label of psychotropic medications in European Psychiatry
    Gorwood, P.
    Frangou, S.
    Heun, R.
    [J]. EUROPEAN PSYCHIATRY, 2017, 40 : 123 - 123